Botox is one of a number of pharmaceutical products made in Allergan’s Westport plant. Photograph: Shannon Stapleton/Files/Reuters

Allergan, the maker of Botox, has agreed to sell itself in a $66 billion (€53 billion) deal with fellow drugs group Actavis, with rival Valeant bowing(...)

Botox producer Allergan  is resisting Valeant’s hostile offer. Photograph: Shannon Stapleton/Reuters

Valeant Pharmaceuticals said in a letter yesterday to Allergan’s board of directors that it was prepared to raise its offer to at least $200 per share(...)

Billionaire investor William Ackman. Photograph: Scott Eells/Bloomberg

A few months ago an innovative partnership between Valeant Pharmaceuticals and billionaire investor William Ackman to buy Botox maker Allergan look(...)

Botox is one of Allergan’s products. Photograph: Bloomberg

On Wall Street, financial engineering masquerades as vision. When it works, you get to be called the Oracle of somewhere or other. If it works for onl(...)

 Minister for Jobs, Enterprise and Innovation, Richard Bruton speaking to the media last month following the announcement by Bausch and Lomb to lay off 200 people and close the Waterford facility if agreement on pay cuts of 20% for the remaining staff were not reached.  Photograph: Collins

Minister for Jobs Richard Bruton has welcomed news that the Bausch & Lomb facility in Waterford is to remain open after employees voted in favour (...)

The head offices of Valeant Pharmaceuticals  in Laval, Quebec. The Canadian-based company said Allergan’s refusal to enter talks left it with no option but to go hostile in the battle for control of its US rival. Photograph: Christinne Muschi/Reuters

Valeant Pharmaceuticals is preparing to take its bid for Allergan direct to shareholders after its latest $53 billion offer was rejected by the mak(...)

The Irish Ambassador to the US confirmed in a letter to Fine Gael TD John Deasy (above) that, following his request, the Embassy in Washington got in contact with the New York office of  senator Charles Schumer. Photograph: Cyril Byrne

The Irish Embassy in Washington DC has contacted a US senator to raise concerns over his call for more than 1,100 at-risk jobs at a pharmaceutical gia(...)

Workers leaving the Bausch & Lomb plant in Waterford yesterday. Photograph: Mary Browne

“Valeant’s model of cutting and slashing really doesn’t work for more than a very short period of time.”The words are those of Allergan chief executiv(...)

A drop of Allergan Inc Botox is seen on the tip of a needle. Valeant’s new offer included a contingent value right that could be worth an extra $7.6 billion. Photograph: Bloomberg

The battle for Botox-maker Allergan took a new twist yesterday when Canadian drugs firm Valeant sold off its skin fillers business, giving it the fir(...)

Shares of Botox maker Allergan jumped 15% after unorthodox takeover by Canadian company Valeant was announced. Photograph: Jonathan Alcorn/Bloomberg

The pharmaceutical industry is regaining its swagger, as companies turn to big and sometimes daring deals to expand and reshape their operation(...)